Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of Methylation Patterns in Hepatocellular Carcinoma

NCT04264754 is registered in ClinicalTrials.gov with Nucleix Ltd. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04264754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of Methylation Patterns in Hepatocellular Carcinoma
Lead sponsor
Nucleix Ltd.
Phase
Observational
Overall status
Terminated
Start date
February 13, 2018
Completion date
February 1, 2021
Enrollment
120 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, hepatocellular cancer, hepatocellular carcinoma